RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

NanoViricides Net Income 2024

NanoViricides Net Income

-8.11 M USD

NanoViricides Dividend yield

Ticker

NNVC

ISIN

US6300873022

WKN

A2PSNF

In 2024, NanoViricides's profit amounted to -8.11 M USD, a -5.58% increase from the -8.59 M USD profit recorded in the previous year.

The NanoViricides Net Income history

YEARNET INCOME (undefined USD)
2029e-
2028e-
2027e-
2026e-
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-
2014-
2013-
2012-
2011-
2010-
2009-
2008-
2007-
2006-

NanoViricides Aktienanalyse

What does NanoViricides do?

NanoViricides Inc. is a biopharmaceutical company specializing in the development of therapeutics for the treatment of virus infections. The company's unique technology is based on nanoparticles that specifically target and destroy virus cells. The company was founded in 2005 by Farooq Ansari, a former top manager at Pfizer. Together with his team, he quickly recognized the potential of nanotechnology in combating diseases and began developing various products based on this technology. NanoViricides Inc.'s business model is based on the development and commercialization of nanoparticle-based therapeutics in the global health market. The company works closely with leading research and development institutions to expand knowledge and technology in this field. NanoViricides Inc. has several product divisions specializing in combating different virus infections. The main divisions are: - FluCide: Focuses on the development of therapeutics for the treatment of influenza infections. Flu is one of the most widespread virus infections worldwide and can lead to serious complications such as pneumonia. - HerpeCide: Focuses on the development of therapeutics for the treatment of herpesvirus infections, including genital herpes, shingles, and chickenpox. - HIVCide: Focuses on the development of therapeutics for the treatment of HIV infections, aiming to develop a safer and more effective cure for HIV. - RabiCide: Focuses on the development of therapeutics for the treatment of rabies infections. - CoronaCide: Focuses on the development of therapeutics for the treatment of coronaviruses, including SARS-CoV-2, the virus that causes COVID-19. NanoViricides Inc. has a range of products in various stages of development and research, with some already in clinical studies. The company continuously strives to improve its products and expand its research and development efforts. In summary, NanoViricides Inc. is a biopharmaceutical company specializing in the development of therapeutics for the treatment of virus infections. It utilizes a unique technology based on nanoparticles to directly combat viruses at the cellular level. With multiple product divisions and a strong team of researchers and developers, NanoViricides Inc. is continuously working to improve the health of patients worldwide. The answer is: NanoViricides Inc. is a biopharmaceutical company specializing in the development of therapeutics for virus infections using nanoparticle-based technology. NanoViricides ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding NanoViricides's Profit Margins

The profit margins of NanoViricides represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of NanoViricides's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating NanoViricides's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

NanoViricides's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When NanoViricides’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about NanoViricides Stock

How much profit has NanoViricides made this year?

NanoViricides has made -8.11 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -5.58% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does NanoViricides publish its earnings?

NanoViricides publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of NanoViricides?

The profits of NanoViricides are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of NanoViricides?

You can learn more about the earnings of NanoViricides by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does NanoViricides pay?

Over the past 12 months, NanoViricides paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, NanoViricides is expected to pay a dividend of 0 USD.

What is the dividend yield of NanoViricides?

The current dividend yield of NanoViricides is .

When does NanoViricides pay dividends?

NanoViricides pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of NanoViricides?

NanoViricides paid dividends every year for the past 0 years.

What is the dividend of NanoViricides?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is NanoViricides located?

NanoViricides is assigned to the 'Health' sector.

Wann musste ich die Aktien von NanoViricides kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of NanoViricides from 6/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.

When did NanoViricides pay the last dividend?

The last dividend was paid out on 6/3/2024.

What was the dividend of NanoViricides in the year 2023?

In the year 2023, NanoViricides distributed 0 USD as dividends.

In which currency does NanoViricides pay out the dividend?

The dividends of NanoViricides are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von NanoViricides

Our stock analysis for NanoViricides Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NanoViricides Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.